Article
Adoptive T-Cell Therapy for Solid Tumors
2017-01-01
Abstract excerpt
Chimeric antigen receptor (CAR) T-cell therapy is an innovative form of immunotherapy wherein autologous T cells are genetically modified to express chimeric receptors encoding an antigen-specific single-chain variable fragment and various costimulatory molecules. Upon administration, these modified T cells traffic to, and recognize, cancer cells in an HLA-independent manner. CAR T-cell therapy has shown remarkabl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 30bb8a76-7877-5729-8b25-44925398f9ec
- DOI
- 10.14694/edbk_180328
